COVID-19: combining antiviral and anti-inflammatory treatments
- PMID: 32113509
- PMCID: PMC7158903
- DOI: 10.1016/S1473-3099(20)30132-8
COVID-19: combining antiviral and anti-inflammatory treatments
Comment in
-
Baricitinib for COVID-19: a suitable treatment?Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3. Lancet Infect Dis. 2020. PMID: 32251638 Free PMC article. No abstract available.
-
Baricitinib for COVID-19: a suitable treatment? - Authors' reply.Lancet Infect Dis. 2020 Sep;20(9):1013-1014. doi: 10.1016/S1473-3099(20)30270-X. Epub 2020 Apr 3. Lancet Infect Dis. 2020. PMID: 32251639 Free PMC article. No abstract available.
Comment on
-
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. Lancet. 2020. PMID: 32032529 Free PMC article. No abstract available.
References
-
- Segler MHS, Preuss M, Waller P. Planning chemical syntheses with deep neural networks and symbolic AI. Nature. 2018;555:604–610. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
